Unlock Asia-Pacific: Present at MedTech World Asia | Hong Kong 2026

The Asia-Pacific MedTech market is not waiting for anyone. At over $140 billion and growing at 8.4% annually (nearly double the rate of the US and European markets), APAC is the fastest-moving healthcare innovation corridor on the planet. The question for MedTech companies is no longer whether to move here. It’s how fast, and through which door.

That door is Hong Kong. And from 26 to 28 August 2026, MedTech World Asia opens it wide.

Why Hong Kong?

Every MedTech founder, commercial director, and investor eventually faces the same question when approaching Asia-Pacific: where do I plant my flag first?

Singapore has its strengths. Tokyo has its depth. Shanghai has its scale. But Hong Kong sits at the intersection of three forces that, together, make it the only true gateway into the entire region.

Western-standard trust

Hong Kong operates under a common law framework with regulatory norms that Western companies immediately recognise. IP protections are robust. Contracts are enforceable. For a MedTech company bringing clinical-stage technology into Asia, this is not a minor convenience. It is the foundation of confidence.

Greater Bay Area manufacturing

Within a 90-minute radius sits one of the most sophisticated medical device manufacturing ecosystems in the world. Thousands of contract manufacturers and engineering partners across Shenzhen, Guangzhou, and the wider GBA can take a prototype from bench to production at a speed and cost that no Western market can match.

Direct China market access

Mainland China is the single largest growth opportunity in global healthcare. An ageing population, a growing middle class, and accelerating government spending on health infrastructure make it a market no serious MedTech player can ignore. Hong Kong’s unique status gives companies a structured, de-risked path in, without the complexity of entering the mainland cold.

No other city combines these three. That is why MedTech World is bringing its Asia flagship here.

A stage that puts you in front of the right room

A Company Showcase at MedTech World Asia is not a booth. It is a dedicated moment on stage, in front of an audience that has come specifically to find what you are building.

The room will hold investors actively deploying capital into APAC healthcare, hospital procurement leads and health system executives from across the region, and strategic partners looking for exactly the kind of company you are.

In a matter of minutes, the right presentation here can accomplish what months of cold outreach cannot. The questions that follow. The introductions made over dinner. The follow-up that lands in your inbox on the flight home. This is what the MedTech World stage is built for.

The moment to move

With APAC projected to reach $225 billion by 2030, the companies building distribution networks, clinical partnerships, and brand recognition in the region today are not chasing a future opportunity. They are securing a present one before the window narrows.

MedTech World Asia runs across three days at the Hong Kong Convention and Exhibition Centre, bringing together MedTech companies, investors, health system leaders, and strategic partners from across the region and beyond.

Company Showcase slots are limited. The presenters who take the stage in August will be the companies that recognised the moment and acted.

Claim your presenting slot at MedTech World Asia 2026 now.

Investors and family offices looking to connect with emerging MedTech companies can register their interest through the Investor Pass form here.